Log In
Print this Print this

AAVLP (HPV16/31L2)

  Manage Alerts
Collapse Summary General Information
Company Medigene AG
DescriptionAdeno-associated virus-like particles (AAVLPs) presenting HPV minor capsid protein L2 peptides from HPV types 16 and 31
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine: Viral vaccine
Latest Stage of DevelopmentPreclinical
Standard IndicationHuman papillomavirus (HPV)
Indication DetailsPrevent HPV infection
Regulatory Designation
Partner2A Pharma AB

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today